Description

The HOYA iSert PY-60AD is a monofocal intraocular lens (IOL) specifically designed for use in cataract surgery. Its primary function is to restore vision by being implanted in the capsular bag of the eye. Crafted by HOYA, this lens is constructed from hydrophobic acrylic, providing a high-quality optic that includes a blue PMMA material for the haptics, ensuring stability and durability.

Design Features

• Aspheric Optic: The lens features an aspheric, aberration-correcting optic design, enhancing visual clarity by minimizing optical aberrations.
• 3-Piece Construction: This design includes modified C-loop haptics with a 5° angulation, contributing to secure placement within the eye.
• Sharp Optic Edge: Helps reduce posterior capsule opacification (PCO), maintaining long-term visual performance.
• Manufacturing Precision: Lathe-cut and tumble polished for superior quality and performance.

Preloaded Injector System

The iSert PY-60AD comes with a fully preloaded injector system, simplifying the surgical process by reducing handling complexity and eliminating the need for cleaning and sterilization of reusable injectors. The injector tip has an outer diameter of 1.89 mm, facilitating precise implantation.

Optical Specifications

• Optic Diameter: 6.0 mm
• Overall Length: 12.5 mm
• Power Range: Available from +6.00 to +30.00 diopters in 0.50 D increments, allowing customization to individual patient needs.
• UV and Blue Light Filter: Includes a yellow lens to protect the eye from harmful light exposure.

Longevity and Performance

The lens boasts an estimated A-Constant of 118.4, with optimized constants for various calculation formulas, ensuring accurate surgical outcomes. It is designed for a long lifespan, with an expected duration of 20 years, minimizing the need for replacement unless medically necessary.

Considerations and Usage

While there are potential adverse events such as wound leak, dry eye syndrome, and other ocular complications, these are common considerations with intraocular implants. The lens has no known contraindications for adults, though certain medical conditions may require special attention from the surgeon.

Global Impact

Since its launch in 2007, over 10 million of these lenses have been implanted worldwide, demonstrating its reliability and effectiveness. The product is protected by U.S. Patent Nos. 8647383 and 9265603, underscoring its innovative design and trusted performance in the field of ophthalmology.